CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,212 enrolled
Drug / intervention
Prospective observational cohort studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04657211
NCT04657211N/ACompleted
CompareCT.gov

Triple thErapy in paTients With COPD Under Real lIve Setting (the TETRIS Study)

GlaxoSmithKline·observational·Posted Dec 8, 2020·Updated Aug 17, 2025

In Brief

An observational study evaluating Prospective observational cohort study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 1,212 participants across 1 site.

Detailed Summary

TETRIS is a multi-center, prospective observational cohort study. It will include participants with COPD who are on an existing combined treatment of long-acting muscarinic antagonist (LAMA), long-acting beta 2 agonists (LABA) and inhaled corticosteroids (ICS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 8, 2020
Enrollment StartJan 14, 2021
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.6 years ago

Interventions

Prospective observational cohort studyother

prospective observational cohort study